A solid-phase radioimmunoassay was developed for measuring the concentration of antispermatozoa antibodies in the sera of sterile patients. Whole human spermatozoa fixed in methanol and immobilized on plastic microtiter plates were used äs antigens, and the spermatozoa-bound antibodies were quantitated with the aid of [ 125
I]protein-A. The assay is specific, simple to perform and up to 1000 tests can be carried out conveniently by one technician on a single working day. The new test was shown to correlate better with immunological sterility than the sperm microagglutination and immobilisation tests. An antispermatozoa antibody concentration of 210 g/l and above was found be indicative of an immunological cause of infertility. 
Bestimmung der Konzentration gegen Humanspermatozoen gerichteter Antikörper in Seren steriler

Introduction
Several methods have been described for the detection of antispermatozoa antibodies (l--5), Most of these tests rely on judgements of observation. In addition some are known to be adversely effected unspecifically by e. g, hormones or drugs present in the serum of the patient (6) . None of the presently used tests can quantitate the antispermatozoa antibody concentrations in the sera.
In this paper we report the development of a new solid-phase protein-A binding assay that permits the estimation of antispermatozoa antibody concentrations in g/l. (11) . This obviates the need for Inhibition by addition of an amino acid mixture. Following the incubation the [ 125 I)protein-A was purified on a Sephadex-G 25 column. The column was equilibrated and eluted with a 0.01 mol/1 phosphate buffer pH 7.2, containing l g/l gelatin. One ml fractions were collected and the first radioactive peak fraction was aliquoted into 100 μΐ portions. The aliquots were kept at ---20 °C until use.
Purification of antispermatozoa IgG
Different volumes of sera from sterile patients were pooled to give ca. 100 ml and dialyzed against 0.05 mol/1 Tris-HCl buffer pH 6.5 for 72 hours at 4 °C. The spermagglutinating titer of the pooled serum was estimated before dialysis and was found to be positive at l : 512 dilution. The dialysed serum was then applied to a diethylaminoethylcellulose column (1.8x50 cm), which had been previously equilibraied with the above starting buffer. Elution commenced with a linear gradient of 0.1-1 mol/1 NaCl with the same buffer. Ten ml fractions were collected at a flow rate of l .5 ml/h. The fractions in the first peak were tested for purity by radial immunodiffusion and used in the solid-phase assay at a protein concentration of 100 mg/1 (see below).
Preparation of the microtiter plates with target cell antigens Spermatozoa from healthy donors, with normal spermiogram and an average sperm count of 2.5 x 10 10 /1, were washed three times in 0.06 mol/1 phosphate buffer in 0.15 mol/1 NaCl pH 7.2 at 600 g for 10 min at 4 °C.
After the final centrifugation the cells were resuspended in the above buffer at a concentration of 3 x 10 9 /1. The cell Suspension was then distributed in 100 μΐ portions into the U-bottom wells of microtiter plates (Dynatech Laboratories Inc., Massachusetts, U.S.A.). The plates were then centrifuged at 150g for 10 min, 4 °C and the supernatants decanted. Approximately 100 μΐ of methanol was added to each well and the plates were centrifuged for another 10 min. After removal of the supernatants the rest of the methanol was allowed to evaporate. The attached cells were washed three times with 200 μΐ of cold phosphate-buffered saline. The plates were then incubated for 15 min at room temperature in a phosphate buffered saline, containing l g/l bovine serum albumin and 0.5 ml/l Tween-20 and stored at -20 °C until use. Only wells with monolayers of spermatozoa were used for the assays.
Assay validation
Coating the microtiter plates at different t rgel cell c ncentrations
Various c ncentrations of spermatozoa were tried in order to establish optimal assay conditions. The wells were coated with 3 x 10 
Estimation of spermatozoa-bo nd antibody concentration with the purified antispermatozoa IgG
The peak IgG fraction (number 19) was diluted to contain 2000, 200,20 and 2 μg/l IgG with 0.06 mol/1 phosphate buffer pH 7.2 in 0.15 mol/1 NaCl, and assayed in the solid-phase assay. The conditions for the solid-phase assay were the same s described above.
The specific activity of [ 
Adsorption of antispermatozoa antibodies with unfixed human spermatozoa
In order to check whether the spermatozoal membrane antigens are affected by methanol fixation, and t establish specificity, the purified antispermatozoa IgG was adsorbed with fresh human spermatozoa. One hundred microliters of diluted IgG, l: 5000 in 0.06 mol/1 phosphate buffer pH 7.2 containing 0.15 mol/ί NaCl, was incubated with l O 7 washed spermatozoa at a spermatozoa concentration of 10 ! */l for 24 h at 4 °C. Following the incubation the mixture was centrifuged at 6000 g for 30 min and the supefnatant was incubated again with new spermatozoa under the same conditions. This process was repeated twice and finally the supernatant assayed in the solid-phase test.
Adsoφtion of the positive control serum (see quality control) was done similarly, except that the incubation'was repeated only once.
Solid-phase-protein-A binding assay
In the routine assays of patient sera the sera were diluted l : 4 with 0.06 mol/1 phosphate buffer pH 7.2 in 0.15 mol/1 NaCl. One hundred microliters of the diluted sera were pipetted into the microtiter wells and the plates were incubated for 60 min at 25 °C and for 60min at 4°C. Following the incubation the wells were rinsed three times with the ice cold buffer, and 100 μΐ of [ 125 I]protein-A (1.11 kBq) was added to eaeh well. This was followed by another incubation of 60 min at 4 °C. At the end of the incubation the wells were rinsed again with the same buffer and the plastic wells were cut out. Each of the cut out wells was put into a plastic tube (20 x 160 mm) and these were counted in a BF 5000 61 γ-counter for l min each.
Quality control
For an acc rate calculati n of the specific activities of [ 
Test sera
The sera of sterile patients were sent to our laboratory for routine diagnosis of antispermatozoa antibodies. All patients had wanted children for at least one year and no other clinical tests could explain their persistent infertility.
A group of fertile couples, i. e. last child born within the past two years, served s negative controls. The groups included husbands or wives or both.
Sperm-micro-agglutination and immobilisation tests
The microscopic tests of sperm-agglutination and sperm-immobilisation were carried out s described by Friberg (2) and Hjusted & Hjort (l) respectively. 10 '.ίο 5 
Results
Radioiodination of protein-A resulted in specific activities of 222 to 296 kBq/ng protein-A. Keeping the labelled product at -20 °C for up to three weeks had no significant effect on the sensitivity of the immunoassay, when the aliquots were stored with gelatine carrier and the samples were thawed only once. In this study, protein-A with an IgG binding capacity of 11 nag/mg was used throughout. The assay sensitivity and reproducibility was not effected when protein-A with lower binding capacities were tried, but allowances had to be made in calculating the bound IgG concentrations.
The pH of the reaction mixture seems to be an important factor, probably because of the pH dependence of protein-A binding to the IgG subclasses (12) . The assay seems to be optimal at pH 7.2 and this is achieved conveniently by use of phosphate buffered saline.
Various concentrations of the spermatozoa target cells (antigen) showed that under the conditions described maximal binding occurs at 3 x l O 5 spermatozpa per well ( fig. 1 ). Higher cell concentrations resulted in multi layers of the coated cells witho t significant elevation of antibody binding. Therefofe a cell concentration of 3 Χ 10 5 per well was chosen for all assays.
The linearity of the antibody concentration determined against spermatozoa with the logz titer of rabbit antihuman spermatozoa antiserum is shown in figure2. A correlation coefficient of r == 0.989 was obtained, while the C.V. of interassay Variation was 0.08%. Day to day Variation of the control serurn was estimated to be ^0.1 over a period of one year. Non specific binding with normal serum amounted to 0.05 and with phosphate buffered saline to 0.03. The specificity of the solid-phase immuno assay is demonstrated by the fact that absorption of the control serum with unfixed, fresh spermatozoa, prior to the assay, resulted in negative antibody levels ( fig. 2) . Similar results were obtained using normal rabbit serum. DEAE-cellulose affinity chromatography of the pooled patient sera showed an IgG peak in fractions 13-21. Fraction 19 was found to contain the highest anti-spermatozoa antibody concentration. The solidphase immunoassay with that fraction ( fig. 3) The positive control serum, rabbit antihuman spermatozoa antiserum was found to have an average antispermatozoa antibody concentration of 1122μg/l (± 102). Normal rabbit serum showed antibody levels of 41 μg/l, (±12); and the antibody concentration of rabbit antiserum was reduq^d from 1122 μg/l to 57 [ig/l (±16.6) by adsorptioii with human spermatozoa (tab. 1).
The routine assay of the sera of patients revealed a wide r nge of antispermatozoa antibody concentrations from s low s 54 μg/ί to s high s 1098 μg/l. There was also an increasing tendency fof an elevated antispermatozoa antibody concentration with progressive years of persistent i fertility in these groups. The average antispermatozoa antibody concentration ranged from 472 μg/l with patients of one year of wanting pregnancy to 717 μg/l for one patient with a history of 16 years of sterility (tab. 2).
A comparison of the antibody concentrations in the solid-phase assay with the sperm microagglutination and immobilisation tests in sera of a randomly selected subpopulatipn of sterile patients (tab. 2) indic tes a significant disagreement between the two type of tests. Oiily about 15% of the sera in the infertile groups was also positive in the sperm microaggl tination/immobilisatioii tests. In these positive sera there was no correlation betweeij the titers in the sperm agglutination/immobilisation and antispermatozoa antibody concentrations in the solid-phase assay. One ser iii, for example, with an antibody concentration of 1098 μg/l was still negative in the sperm microagglutination arid immobilisation tests. On the other band two of the patients with proven fertility and an antispermatozoal antibody concentration of äs low äs 200 ^ had a positive titer 1:16 in the sperm microagglutination test. Additional false positives of 1:4 to 1:8 were found in the fertile group (tab. 1). In the group of patients with proven fertility the average non-specific antibody concentration was found to be 166 §/1 by the solid-phase assay. This was significantly lower than the antibody concentrations in all the sterility groups (Studenfs ttest, p < 0.05).
Discussion
Radioiodinated protein-A has been used previously to quantitate IgG in various solid and liquid phase immunoassays (8, 9) . As shown previously, the predominant Ig class in sera of sterile patients is IgG (13) . Furthermore, there is a subclass of antispermatozoa IgG antibodies, which is present naturally in sera, and which reacts with staphylococcal protein-A (10 antibody concentration is possible, for which no other tests are available at present. For adequate quality control the specific activity of the radioiodinated protein-A should be accurately estimated and day to day corrections should be made with the aid of the 12S I decay chart.
Where a uniformity of the labelling procedure with regard to specific activity, radiochemical purity etc., cannot be safeguarded, a simple Inhibition assay with cold protein-A can be set up to estimate bound [ 125 I]protein-A in ng. Alternatively, radioiodinated protein-A preparations that are available commercially can also be used.
There is no need to use purified human antispermatozoal IgG for a calibration Standard. It was used in the present work only for initial assay validation tests. A rigorous quality control can also be maintained with a polyvalent positive control serum, which is also available commercially. However, since there may be variations in the antispermatozoa antibody concentrations in the various batches, either the same lot numbers should be used or adjustments made with regard to total protein-A binding. A good positive control serum should give 0.6-0.7 of total binding of [ Similarly there could be some variations in the (hydrophobic) properties of the plastic surface of the microtiter plates that are supplied by the different manufacturers. In our laboratory the plates from Dynatech Co. proved to be of best quality, with regard to reproducibility. The coated plates with spermatozoa can be stored desiccated for prolonged periods ät -20 °C, without affecting the assay reproducibility. The quality of spermatozoa that are used for coating seems to be of lesser importance. In these tests fresh spermatozoa from healthy donors with a normal spermiogram were used throughout. However we also tried coating the plates with spermatozoa that were stored at -20 °C for up to six months, without adverse effects on the assay. The possibility of using soluble spermatozoal antigens in the solidphase assay is being iiivestigated at present. The correlation of the antispermatozoa antibody concentration, estimated by the solid-phase assay, with unexplained persistent infertility could provide a useful diagnostic test in cases of functional disturbances of fertility.
